Hepatic organelle interaction. I. Spectral investigation during drug biotransformation
Cinti, D.L.; Schenkman, J.B.
Molecular Pharmacology 8(3): 327-338
1972
ISSN/ISBN: 0026-895X PMID: 4402749 Document Number: 56985
Document emailed within 1 workday
Related Documents
Ivanetich, K.M.; Lucas, S.; Marsh, J.A.; Ziman, M.R.; Katz, I.D.; Bradshaw, J.J. 1978: Organic compounds. their interaction with and degradation of hepatic microsomal drug-metabolizing enzymes in vitro Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(3): 218-225Schnell, R.C.; Early, J.L. 1981: Interaction between selenium and phenobarbital on drug response and hepatic microsomal enzyme activity in the male rat Research Communications in Chemical Pathology and Pharmacology 32(1): 181-184
Kourounakis, P.N.; Rekka, E.; Hadjipetrou-Kourounakis, L. 1991: Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation Die Pharmazie 46(10): 727-729
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Poupon, R.Y.; Raizman, A.; Brumault, J.C.; Infante, R.; Darnis, F. 1979: Hepatic biotransformation and conjugation of dehydrocholic acid in patients with cirrhosis Gastroenterologie Clinique et Biologique 3(12): 879-884
Horváth, T.; Past, T.; Tatai, Z.; Pár, A.; Kádas, I.; Tapsonyi, Z.; Jávor, T. 1984: Investigation of biotransformation capacity in patients with chronic liver diseases by pharmacokinetic methods: experimental trials Polish Journal of Pharmacology and Pharmacy 36(4): 361-371
Adamska-Dyniewska, H.; Dziekański, S. 1989: Changes in hepatic biotransformation in patients treated with beta-adrenergic drugs and prazosin Polski Tygodnik Lekarski 44(15-16): 361-363
Kalinina, E.V.; Obraztsov, V.V.; Shekhtman, D.G.; Gudkova, O.V.; Kukushkin, N.I.; Saprin, A.N. 1991: Effect of perfluorodecalin on activities of hepatic phase Ii xenobiotic biotransformation enzymes Biochemistry International 24(3): 543-548
Izu, M. 1992: Investigation of hepatic energy metabolism in normothermic hepatic ischemia--comparison between normal and cirrhotic rat liver Nihon Geka Gakkai Zasshi 93(1): 52-61
Couri, D.; Hetland, L.B.; Abdel-Rahman, S.; Weiss, H. 1977: The influence of inhaled ketone solvent vapors on hepatic microsomal biotransformation activities Toxicology and Applied Pharmacology 41(2): 285-289
Fu, L.S.; Peng, R.X. 1992: Effect of ageing on hepatic biotransformation function and microsomal membrane fluidity in rats Yao Xue Xue Bao 27(9): 645-650
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Grille, W.; Johnsen, K.; Kolenda, K.D. 1979: Conditions for the occurrence of drug interactions during biotransformation Medizinische Klinik 74(3): 55-67
Riska, P.; Lamson, M.; MacGregor, T.; Sabo, J.; Hattox, S.; Pav, J.; Keirns, J. 1999: Disposition and biotransformation of the antiretroviral drug nevirapine in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(8): 895-901
Kellner, H.M.; Arnold, C.; Christ, O.E.; Eckert, H.G.; Herok, J.; Hornke, I.; Rupp, W. 1981: Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration Arzneimittel-Forschung 31(8a): 1337-1353
Warrington, J.S.; Shader, R.I.; von Moltke, L.L.; Greenblatt, D.J. 2000: In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(4): 392-397
Raynaud, F.I.; Boxall, F.E.; Goddard, P.; Barnard, C.F.; Murrer, B.A.; Kelland, L.R. 1996: Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products Anticancer Research 16(4a): 1857-1862
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Gupta, R.; Wu, J.J.; Levin, E.; Koo, J.Y.M.; Liao, W. 2013: Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient Journal of Drugs in Dermatology: Jdd 12(10): 1089
Davidson, K.W.; Kahn, A.; Price, R.D. 1987: Reduction of adverse drug reactions by computerized drug interaction screening Journal of Family Practice 25(4): 371-375